| 0.3 |
1.8 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 |
0.7 |
GO:0002856 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.2 |
0.6 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.2 |
0.7 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.2 |
0.5 |
GO:2000364 |
regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 0.2 |
0.9 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.2 |
0.8 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 |
0.4 |
GO:0072616 |
interleukin-18 secretion(GO:0072616) |
| 0.1 |
0.4 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 0.1 |
0.4 |
GO:0045553 |
TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.1 |
1.0 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.1 |
0.6 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 |
0.6 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 |
1.1 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.1 |
0.3 |
GO:0043311 |
positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.1 |
0.7 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.1 |
0.4 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.1 |
0.1 |
GO:0002763 |
positive regulation of myeloid leukocyte differentiation(GO:0002763) |
| 0.1 |
0.3 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.1 |
GO:0006349 |
regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.1 |
1.0 |
GO:0070487 |
monocyte aggregation(GO:0070487) |
| 0.1 |
0.2 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 |
0.2 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.1 |
0.2 |
GO:1904017 |
cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 |
0.6 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
0.1 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
0.3 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.1 |
0.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
1.7 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
0.2 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.1 |
0.2 |
GO:0003220 |
left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.2 |
GO:0018262 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.1 |
0.2 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.1 |
0.4 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
0.2 |
GO:0072684 |
tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.1 |
0.2 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.1 |
0.1 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
| 0.1 |
0.3 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.1 |
0.1 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.0 |
0.4 |
GO:0002005 |
angiotensin catabolic process in blood(GO:0002005) |
| 0.0 |
0.0 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.0 |
0.6 |
GO:0001915 |
negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.0 |
0.2 |
GO:1903899 |
positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.0 |
0.0 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 0.0 |
0.7 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.3 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.0 |
0.2 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.0 |
0.1 |
GO:0045083 |
negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.0 |
0.2 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.0 |
0.1 |
GO:0002584 |
negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
| 0.0 |
0.6 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 |
0.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.1 |
GO:0016068 |
regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
| 0.0 |
0.5 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.0 |
0.0 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.0 |
0.0 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 |
0.2 |
GO:0072334 |
UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.0 |
0.3 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.0 |
0.1 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 |
0.0 |
GO:0035546 |
interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) |
| 0.0 |
0.3 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 |
0.6 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 |
0.3 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.0 |
0.3 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.0 |
0.2 |
GO:1903517 |
regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.0 |
3.9 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.0 |
0.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.2 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.0 |
0.2 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.0 |
0.0 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.0 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.0 |
0.1 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.0 |
0.1 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.0 |
0.6 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.1 |
GO:1901804 |
beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
| 0.0 |
0.2 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.0 |
0.1 |
GO:2000338 |
interleukin-15 production(GO:0032618) chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
| 0.0 |
0.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.1 |
GO:0042640 |
anagen(GO:0042640) |
| 0.0 |
0.5 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.0 |
0.4 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.0 |
0.3 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.2 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.0 |
0.0 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.0 |
0.1 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.0 |
0.2 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 |
0.1 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.0 |
0.2 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.0 |
0.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 |
0.5 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.1 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.0 |
0.1 |
GO:0002740 |
negative regulation of cytokine secretion involved in immune response(GO:0002740) |
| 0.0 |
0.2 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 0.0 |
0.1 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) |
| 0.0 |
0.1 |
GO:0039007 |
pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) Kupffer's vesicle development(GO:0070121) |
| 0.0 |
0.3 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.0 |
0.1 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.0 |
0.1 |
GO:1903216 |
regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.0 |
0.1 |
GO:0086055 |
atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 0.0 |
0.0 |
GO:0032918 |
putrescine catabolic process(GO:0009447) polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.3 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.0 |
0.1 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.3 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.1 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.0 |
0.1 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.0 |
0.1 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
| 0.0 |
0.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.1 |
GO:0002877 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
| 0.0 |
0.1 |
GO:1902741 |
interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.0 |
0.1 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.0 |
0.1 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.0 |
0.1 |
GO:1902378 |
vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.0 |
0.2 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.0 |
0.0 |
GO:0035482 |
gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.0 |
0.2 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 |
0.1 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.0 |
0.1 |
GO:2000974 |
negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.0 |
0.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.0 |
0.1 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.0 |
0.2 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
| 0.0 |
1.0 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.0 |
0.3 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.0 |
0.4 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 |
0.0 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.0 |
0.2 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.0 |
0.3 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.0 |
0.1 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.0 |
0.0 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.0 |
0.3 |
GO:0002826 |
negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.0 |
0.1 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.3 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.2 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 0.0 |
0.1 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.0 |
0.1 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.0 |
0.1 |
GO:2000612 |
pronephric field specification(GO:0039003) pattern specification involved in pronephros development(GO:0039017) thyroid-stimulating hormone secretion(GO:0070460) kidney field specification(GO:0072004) DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.0 |
0.1 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.0 |
0.1 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.0 |
0.1 |
GO:0033242 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.0 |
0.1 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.0 |
0.2 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.0 |
0.1 |
GO:2000657 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.0 |
0.1 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.0 |
0.2 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.0 |
0.0 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.1 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.0 |
0.1 |
GO:0070294 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.0 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.1 |
GO:0016062 |
adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.0 |
0.1 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 0.0 |
0.0 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.0 |
0.1 |
GO:0090481 |
pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.0 |
0.1 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.0 |
0.9 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 |
0.0 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.0 |
0.1 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.0 |
0.1 |
GO:0006286 |
base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
| 0.0 |
0.1 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.0 |
0.2 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 |
0.1 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 |
0.1 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.0 |
0.1 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.1 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.0 |
0.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.0 |
0.1 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.0 |
0.2 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.0 |
0.0 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.0 |
0.1 |
GO:0072737 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.0 |
0.1 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.0 |
0.1 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.0 |
0.1 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.0 |
0.1 |
GO:1904882 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.0 |
0.0 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.0 |
0.2 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.2 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.0 |
0.1 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.0 |
0.1 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.1 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.0 |
0.1 |
GO:0006117 |
acetaldehyde metabolic process(GO:0006117) |
| 0.0 |
0.1 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 |
0.2 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.1 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.0 |
0.1 |
GO:0051261 |
protein depolymerization(GO:0051261) |
| 0.0 |
0.1 |
GO:0003169 |
coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.0 |
0.1 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 0.0 |
0.1 |
GO:1900098 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) regulation of lactation(GO:1903487) positive regulation of lactation(GO:1903489) |
| 0.0 |
0.1 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 0.0 |
0.1 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.0 |
0.1 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.0 |
0.1 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.0 |
0.2 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 |
0.1 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) |
| 0.0 |
0.2 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.0 |
0.1 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.0 |
0.0 |
GO:1903061 |
positive regulation of protein lipidation(GO:1903061) |
| 0.0 |
0.1 |
GO:0015887 |
biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.0 |
0.1 |
GO:2000639 |
regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.0 |
0.0 |
GO:0070723 |
response to cholesterol(GO:0070723) |
| 0.0 |
0.0 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.0 |
0.1 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.0 |
0.1 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.0 |
0.6 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.9 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.1 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.1 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 0.0 |
0.3 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.0 |
0.0 |
GO:2001183 |
negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.0 |
0.0 |
GO:1904954 |
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
| 0.0 |
0.1 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.0 |
0.2 |
GO:0042426 |
choline catabolic process(GO:0042426) |
| 0.0 |
0.6 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 |
0.1 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.0 |
0.1 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.0 |
0.1 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 |
0.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.4 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.1 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.0 |
0.1 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.0 |
0.0 |
GO:0043634 |
polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.0 |
0.1 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.0 |
0.0 |
GO:0051685 |
maintenance of ER location(GO:0051685) |
| 0.0 |
0.0 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.0 |
0.1 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.0 |
0.1 |
GO:0021564 |
vagus nerve development(GO:0021564) |
| 0.0 |
0.3 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.0 |
GO:0038044 |
transforming growth factor-beta secretion(GO:0038044) |
| 0.0 |
0.1 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.0 |
0.0 |
GO:0051250 |
negative regulation of lymphocyte activation(GO:0051250) |
| 0.0 |
0.1 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.0 |
0.0 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.0 |
0.0 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.0 |
0.0 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.0 |
0.1 |
GO:0061053 |
somite development(GO:0061053) |
| 0.0 |
0.0 |
GO:0051461 |
positive regulation of corticotropin secretion(GO:0051461) |
| 0.0 |
0.0 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.0 |
0.1 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.0 |
0.0 |
GO:1902474 |
regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 |
0.0 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.0 |
0.1 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 0.0 |
0.1 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.0 |
0.1 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.0 |
0.3 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.1 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.0 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.0 |
0.1 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.0 |
0.1 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.0 |
0.6 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.0 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.0 |
0.1 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.0 |
0.0 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.0 |
0.1 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.0 |
0.0 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.0 |
0.0 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.0 |
0.0 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.0 |
0.6 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.0 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 |
0.1 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.0 |
0.1 |
GO:2000288 |
positive regulation of myoblast proliferation(GO:2000288) |
| 0.0 |
0.0 |
GO:0002606 |
positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.0 |
0.1 |
GO:0033088 |
regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.0 |
0.1 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.0 |
0.2 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.0 |
0.1 |
GO:0021766 |
hippocampus development(GO:0021766) |
| 0.0 |
0.0 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.0 |
0.0 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.0 |
0.1 |
GO:0071386 |
cellular response to corticosterone stimulus(GO:0071386) |
| 0.0 |
0.3 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.0 |
0.0 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.0 |
0.1 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 |
0.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.2 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.0 |
GO:0070429 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.0 |
0.1 |
GO:0098967 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.0 |
0.0 |
GO:0031650 |
regulation of heat generation(GO:0031650) |
| 0.0 |
0.0 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.0 |
0.1 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.0 |
0.1 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.0 |
0.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.0 |
0.0 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.0 |
0.0 |
GO:0034130 |
toll-like receptor 1 signaling pathway(GO:0034130) |
| 0.0 |
0.0 |
GO:0009826 |
unidimensional cell growth(GO:0009826) |
| 0.0 |
0.2 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.0 |
0.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.1 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.1 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.0 |
0.1 |
GO:0032275 |
luteinizing hormone secretion(GO:0032275) |
| 0.0 |
0.1 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.0 |
0.1 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.0 |
0.1 |
GO:0036229 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.0 |
0.3 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.0 |
0.1 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.2 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.0 |
0.1 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.0 |
0.3 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.1 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.0 |
0.3 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.3 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.7 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.0 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.0 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 |
0.0 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.0 |
0.1 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.0 |
0.1 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.0 |
0.1 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.0 |
0.0 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 |
0.2 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.3 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.0 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.0 |
0.0 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.0 |
0.1 |
GO:1904764 |
negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.0 |
0.3 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
0.8 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.0 |
0.1 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.0 |
0.1 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.0 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.0 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.0 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 |
0.1 |
GO:2001295 |
malonyl-CoA biosynthetic process(GO:2001295) |
| 0.0 |
0.0 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.0 |
0.0 |
GO:1903984 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.0 |
0.1 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.0 |
0.1 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.2 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.0 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.0 |
0.2 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 |
0.0 |
GO:1903660 |
negative regulation of complement-dependent cytotoxicity(GO:1903660) |
| 0.0 |
0.0 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.0 |
0.0 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.0 |
0.0 |
GO:1900248 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.0 |
0.2 |
GO:1901078 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.0 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.0 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.0 |
0.1 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.0 |
0.1 |
GO:0007620 |
copulation(GO:0007620) |
| 0.0 |
0.0 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.0 |
0.1 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.0 |
0.0 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.0 |
0.1 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 |
0.0 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.0 |
0.2 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) |
| 0.0 |
0.0 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.0 |
0.3 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.0 |
0.0 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.0 |
0.0 |
GO:1902576 |
negative regulation of nuclear cell cycle DNA replication(GO:1902576) |
| 0.0 |
0.0 |
GO:1904504 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.0 |
0.1 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.0 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 |
0.2 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.1 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 |
0.0 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.0 |
0.0 |
GO:0090402 |
oncogene-induced cell senescence(GO:0090402) |
| 0.0 |
0.2 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.0 |
0.2 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.0 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.0 |
0.1 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 |
0.4 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 |
0.2 |
GO:0009086 |
methionine biosynthetic process(GO:0009086) |
| 0.0 |
0.2 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 |
0.1 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.0 |
GO:0061525 |
hindgut development(GO:0061525) |
| 0.0 |
0.1 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.0 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.0 |
0.1 |
GO:0060754 |
regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.0 |
0.0 |
GO:0032306 |
regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.0 |
0.1 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.0 |
0.2 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
0.1 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.1 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.0 |
0.0 |
GO:0090345 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.0 |
0.1 |
GO:0097466 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.0 |
0.2 |
GO:0034656 |
nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 |
0.0 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 |
0.0 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.0 |
0.1 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.0 |
0.2 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.0 |
0.0 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.0 |
0.1 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.0 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.0 |
0.0 |
GO:0007512 |
adult heart development(GO:0007512) |
